Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL)

Acta Diabetologica

Volumn 44, Issue 3, 2007, Pages 99-105

  Mazza, A ^a   Zamboni, S ^a   Rizzato, E ^a   Pessina, A C ^b   Tikhonoff, V ^b   Schiavon, L ^b   Casiglia, E ^b  

^a ROVIGO GENERAL HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Coronary; Elderly; J shaped; Mortality; Relative risk; Uric acid

Indexed keywords

AGED; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SURVIVAL RATE; URIC ACID BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL; CORONARY DISEASE; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LIPIDS; MALE; RISK FACTORS; URIC ACID;

EID: 34548157452     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0249-3     Document Type: Article

References (32)

1. Gertler MM, Garn SM, Levine SA (1951) Serum uric acid in relation to age and physique in health and coronary heart disease. Ann Intern Med 34:1421-1431
2. Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality. The NHANES I epidemiological follow-up 1971-1992. JAMA 283:2404-2410
3. Alderman MH, Cohen H, Madhavan S, Kivlighn S (1999) Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 34:144-150
4. Franse LV, Pahor M, Di Bari M, Shorr RI, Wan JY, Somes GW, Applegate WB (2000) Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 18:1149-1154
5. - (1985) Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors. The Hypertension Detection and Follow-up Program Cooperative Research Group. Prev Med 14:312-335
6. Bengtsson C, Lapidus L, Stendahl C, Waldenstrom J (1988) Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 224:549-555
7. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J (1989) Serum uric acid and 11.5-year mortality of middleaged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 42:257-267
8. Wannamethee SG, Shaper AG, Whincup PH (1997) Serum urate and risk of major coronary heart disease events. Heart 78:147-153
9. Liese AD, Hense HW, Löwel H, Döring A, Tietze M, Keil U (1999) Association of serum uric acid with all cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. Epidemiology 10:391-397
10. Brand FN, McGee DL, Kannel WB, Stokes J, Castelli WP (1985) Hyperuricemia a a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 121:11-18
11. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD (2000) Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 10:136-143
12. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST (1995) Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol 142:288-294
13. Wang JG, Staessen JA, Fagard RH, Birkenhäger WH, Gong L, Liu L (2001) Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 37:1069-1074
14. Golik A, Weissgarten J, Cotariu D, Cohen N, Zaidenstein R, Ramot Y, Averbukh Z, Modai D (1993) Renal uric acid handling in non-insulin-dependent diabetic patients with elevated glomerular filtration rates. Clin Sci 85:713-716
15. Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G (2001) Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 31:318-321
16. Facchini F, Chen YDI, Hollenbeck CB, Reaven GM (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008-3011
17. Casiglia E, Spolaore P, Mormino P, Maschio O, Colangeli G, Celegon L, Maggiolo G, Tittoto L, Pasinato A, Ambrosio GB (1991) The CASTEL project (CArdiovascular STudy in the ELderly): protocol, study design, and preliminary results of the initial survey. Cardiologia 36:569-576
18. Ledru F, Ducimetiere P, Battaglia S, Courbon D, Beverelli F, Guize L, Guermonprez JL, Diebold B (2001) New diagnostic criteria for diabetes and coronary artery disease: Insights from an angiographic study. J Am Coll Cardiol 37:1543-1550
19. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-35
20. Nicoll SR, Sainsburg R, Bailey RR, King A, Frampton C, Elliot JR (1991) Assessment of creatinine clearance in healthy subjects over 65 years of age. Nephron 59:621-625
21. Abbott RD, Brand FN, Kannel WB, Castelli WP (1988) Gout and coronary heart disease: the Framingham study. J Clin Epidemiol 41:237-242
22. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG (2005) Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69:928-933
23. Wheeler JG, Juzwishin KDM, Eiriksdottir G, Gudnason V, Danesh J (2005) Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. Plos Medicine 2:236-243
24. Suarna C, Dean RT, May J, Stocker R (1995) Human atherosclerotic plaque contains both axidiazed lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol 15:1616-1624
25. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF, Barnett AH (1997) Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabete mellitus. Eur J Clin Invest 27:484-490
26. Ceriello A, Bortolotti N, Pirisi M, Crescentini A, Tonutti L, Motz E, Russo A, Giacomello R, Stel G, Taboga C (1997) Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care 20:1589-1593
27. Ginsberg MH, Kozin F, O'Malley M, McCarty DJ (1977) Release of platelet constituents by monosodium urate crystals. J Clin Invest 60:999-1007
28. Alderman M, Kala JVA (2004) Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin 20:369-379
29. Hsu SP, Pai MF, Peng SJ, Chiang CK, Ho TI, Hung KY (2004) Serum uric levels show a J-shaped trend association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant 19:457-462
30. Shichiri M, Iwamoto H, Marumo F (1990) Diabetic hypouricemia as an indicator of clinical nephropathy. Am J Nephrol 10:115-122
31. Tuttle KR, Short RA, Johnson JR (2001) Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 15:1411-1414
32. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D (2003) Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Executive summary. Eur Heart J 24:1601-1610